Altered production of immunoregulatory cytokines by invariant Vα19 TCR-bearing cells dependent on the duration and intensity of TCR engagement

International Immunology

Volumn 21, Issue 2, 2009, Pages 179-185

  Shimamura, Michio ^a,b   Huang, Yi Ying ^a   Kobayashi, Masumi ^a   Goji, Hiroshi ^a  

^a MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Cytokine; Immunoregulation; Invariant TCR; NKT cell

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG; VALPHA19 T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE REGULATION; CELL KINETICS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE FUNCTION; IMMUNOREGULATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, LY; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; GENES, T-CELL RECEPTOR ALPHA; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PROTEIN BINDING; PROTEIN STABILITY; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TH2 CELLS;

EID: 59549093116     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn136     Document Type: Article

References (24)

1. Kantor, A. B. and Herzenberg, L. A. 1993. Origin of murine B cell lineage. Annu. Rev. Immunol. 11:501.
2. Haas, W., Pereira, P. and Tonegawa, S. 1993. Gamma/delta cells. Annu. Rev. Immunol. 11:637.
3. Bendelac, A., Mivera, N. R., Park, S.-H. and Roark, J. H. 1997. Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu. Rev. Immunol. 15:535.
4. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, T. 2003. The regulatory role of Vα14 NKTcells in innate and acquired immune response. Annu. Rev. Immunol. 21:483.
5. Bendelac, A., Hunzike, R. D. and Lantz, O. 1998. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184:1285.
6. Tilloy, F., Treiner, E., Park, S.-H. et al. 1999. An invariant T cell receptor α chain define a novel TAP-independent major histo-compatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J. Exp. Med. 189:1967.
7. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant a chain. J. Exp. Med. 178:1.
8. Shimamura, M. and Huang, Y.-Y. 2002. Presence of a novel subset of NKT cells bearing an invariant Vα19.1-Jα26 TCR α chain. FEBS Lett. 516:97.
9. Treiner, E., Duban, L., Bahram, S. et al. 2003. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422:164.
10. Hashimoto, K., Hirai, M. and Kurosawa, Y. 1995. A gene outside the human MHC related to classical HLA class I genes. Science 269:693.
11. Huang, S., Gilfilan, S., Kim, S. et al. 2008. MR1 uses a endocytic pathway to activate mucosal-associated invariant T cells. J. Exp. Med. 205:1201.
12. llés, Z., Shimamura, M., Newcombe, J., Oka, N. and Yamamura, T. 2004. Accumulation of Vα7.2-Jα33 invariant T cells in human autoimmune inflammatory lesions. Int. Immunol. 16:223.
13. Kawachi, I., Maldonado, J., Strader, C. and Gillfillan, S. 2006. MR1-restricted Vα19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J. Immunol. 176:1618.
14. Okamoto, N., Kanie, O., Huang, Y.-Y., Fujii, R., Watanabe, H. and Shimamura, M. 2005. Synthetic α-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Vα19- Jα26 TCR α chain. Chem. Biol. 12:677.
15. Croxford, J. L., Miyake, S., Huang, Y.-Y., Shimamura, M. and Yamamura, T. 2006. Invariant Vα19i T cells regulate autoimmune inflammation. Nat. Immunol. 7:987.
16. + cells in the liver with potential to promptly respond to TCR stimulation. Immunol. Lett. 121:38.
17. Smiley, S. T., Kaplan, M. N. and Grusby, M. J. 2001. Immunoglobulin E production in the absence of interleukin 4-secreting CD1-dependent cells. Science 275:977.
18. Mombaerts, P., Clarke, A. R., Rudnicki, M. A. et al. 1992. Mutations in T cell receptor genes a and b block thymocyte development at different stages. Nature 360:225.
19. + T cells in vitro from fetal liver precursors. J. Immunol. 158:3682.
20. Oki, S., Chiba, A., Yamamura, T. and Miyake, S. 2004. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NK T cells. J. Clin. Invest. 113:1631.
21. Sakuishi, K., Oki, S., Araki, M., Porcelli, S. A., Miyake, S. and Yamamura, T. 2007. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J. Immunol. 179: 3452.
22. Furuzawa-Carballeda, J., Varges-Rojas, M. I. and Cabral, A. R. 2007. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6:169.
23. Shimamura, M., Okamoto, N., Huang, Y.-Y. et al. 2007. Modulation of Vα19 NKT cell immune responses by α-mannosyl ceramide derivatives consisting of a series of modified sphingosines. Eur. J. Immunol. 37:1836.
24. Shimamura, M., Huang, Y.-Y., Okamoto, N. et al. 2007. Glycolipids with non-reducing end α-mannosyl residues that have potentials to activate invariant Vα19 NKT cells. FEBS J. 274:2921.